Details for Patent: 8,648,097
✉ Email this page to a colleague
Which drugs does patent 8,648,097 protect, and when does it expire?
Patent 8,648,097 protects OMLONTI and is included in one NDA.
This patent has twenty-three patent family members in seventeen countries.
Drugs Protected by US Patent 8,648,097
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Visiox Pharma | OMLONTI | omidenepag isopropyl | SOLUTION;OPHTHALMIC | 215092-001 | Sep 22, 2022 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | Y | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,648,097
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2009224329 | ⤷ Subscribe | |||
| Canada | 2718393 | ⤷ Subscribe | |||
| China | 101970410 | ⤷ Subscribe | |||
| China | 103965099 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
